Author

Tamara R. Anderegg

Observed names: T Anderegg, T. R. Anderegg, T.R Anderegg, T.R. Anderegg

Institutions: Centers for Disease Control and Prevention, JMI Laboratories

Observed institutions: Centers for Disease Control and Prevention, JMI Laboratories

OpenAlex ID: A5002686338

Trends in linezolid susceptibility patterns: report from the 2002–2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program

2005 · Tamara R. Anderegg, Helio S. Sader, et al. · International Journal of Antimicrobial Agents · 57

Trends in linezolid susceptibility patterns in 2002: Report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program

2005 · James E. Ross, Tamara R. Anderegg, et al. · Diagnostic Microbiology and Infectious Disease · 46

Quality Control Guidelines for Testing Gram-Negative Control Strains with Polymyxin B and Colistin (Polymyxin E) by Standardized Methods

2005 · Ronald N. Jones, Tamara R. Anderegg, et al. · Journal of Clinical Microbiology · 42

Initial Quality Control Evaluations for Susceptibility Testing of Dalbavancin (BI397), an Investigational Glycopeptide with Potent Gram-Positive Activity

2003 · Tamara R. Anderegg, Douglas J. Biedenbach, et al. · Journal of Clinical Microbiology · 28

In vitro evaluation of AZD2563, a new oxazolidinone, tested against unusual gram-positive species

2002 · Ronald N. Jones, Douglas J. Biedenbach, et al. · Diagnostic Microbiology and Infectious Disease · 18

Quality Control Guidelines for MIC Susceptibility Testing of Omiganan Pentahydrochloride (MBI 226), a Novel Antimicrobial Peptide

2004 · Tamara R. Anderegg, Thomas R. Fritsche, et al. · Journal of Clinical Microbiology · 16

AZD2563, a new oxazolidinone: bactericidal activity and synergy studies combined with gentamicin or vancomycin against staphylococci and streptococcal strains

2002 · R.N. Jones, T.R. Anderegg, et al. · Diagnostic Microbiology and Infectious Disease · 16

In Vitro Evaluation of AZD2563, a Novel Oxazolidinone, against 603 Recent Staphylococcal Isolates

2002 · Tamara R. Anderegg, Douglas J. Biedenbach, et al. · Antimicrobial Agents and Chemotherapy · 10

Quality Control Guidelines for BAL9141 (Ro 63-9141), an Investigational Cephalosporin, When Reference MIC and Standardized Disk Diffusion Susceptibility Test Methods Are Used

2004 · T. R. Anderegg, R. N. Jones, et al. · Journal of Clinical Microbiology · 9

Quality control guidelines for MIC susceptibility testing of NVP PDF-713: a novel peptide deformylase inhibitor

2003 · Tamara R. Anderegg, Douglas J. Biedenbach, et al. · International Journal of Antimicrobial Agents · 9

Bactericidal activity of garenoxacin tested by kill-curve methodology against wild type and QRDR mutant strains of Streptococcus pneumoniae

2004 · Tamara R. Anderegg, Ronald N. Jones · Diagnostic Microbiology and Infectious Disease · 7

Preliminary susceptibility testing guidelines for AZD2563, a long-acting oxazolidinone

2003 · T Anderegg · International Journal of Antimicrobial Agents · 6

Validation of commercial dry-form broth microdilution panels for susceptibility testing of AZD2563, a new long-acting oxazolidinone

2003 · R.N. Jones, T.R. Anderegg, et al. · Clinical Microbiology and Infection · 6

Disk diffusion quality control guidelines for NVP-PDF 713: a novel peptide deformylase inhibitor

2004 · Tamara R. Anderegg, Ronald N. Jones · Diagnostic Microbiology and Infectious Disease · 5

In vitro evaluation of AZD2563, a new oxazolidinone, tested against beta-haemolytic and viridans group streptococci

2002 · T. R. Anderegg · Journal of Antimicrobial Chemotherapy · 5

Re-evaluation of quality control guidelines for gatifloxacin and garenoxacin (BMS284756) when susceptibility testing Haemophilus influenzae and Streptococcus pneumoniae

2003 · T.R Anderegg, D.J Biedenbach, et al. · Diagnostic Microbiology and Infectious Disease · 2

Determination of disk diffusion and MIC quality control parameters for AZD2563, a novel long-acting oxazolidinone

2003 · Tamara R. Anderegg, Ronald N. Jones · Diagnostic Microbiology and Infectious Disease · 2

Initial disk diffusion quality control guidelines for tylosin tested against Staphylococcus aureus ATCC 25923 and Streptococcus pneumoniae ATCC 49619

2003 · Tamara R. Anderegg, Ronald N. Jones · International Journal of Antimicrobial Agents · 1

Works count: 20

Citation count: 285

H-index: 9

I10-index: 8